Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
CT-388 would be the only branded dual GLP-1R/GIPR agonist with full exclusivity after tirzepatide faces generic competition in the 2036 to 2041 window
Once you sign up for Blue365 at blue365deals.com/BCBSTX, weekly Featured Deals will be emailed to you
Tirzepatide works for weight loss by decreasing appetite and slowing the movement of food from the stomach into the small intestine, which may make you feel full more quickly and for a longer period of time
A 2023 study published in Diabetes, Obesity, and Metabolism demonstrated that GLP-1 agonist users engaging in regular physical activity experienced better weight loss quality, retaining more muscle mass compared to those who did not exercise
